在土耳其人口中,血管内皮生长因子I/D变体和绝经后骨质疏松症风险
Serbulent Yigit1,2, Ayse Feyda Nursal3, Mehmet Can Nacar4
1Department of Genetics, Faculty of Veterinary Medicine, Ondokuz Mayis University, Samsun, Turkiye.
Nucleosides, nucleotides & nucleic acids
|May 21, 2024
概括
在土耳其妇女中,VEGF I/D 变体 (rs35569394) 与绝经后骨质疏松症 (PMOP) 无关. 需要对不同种族群体进行进一步的研究,以证实这些关于骨质疏松症风险因素的发现.
科学领域:
- 遗传学 遗传学 是一个
- 骨的新陈代谢 骨的新陈代谢
- 内分泌学 在内分泌学.
背景情况:
- 绝经后骨质疏松症 (PMOP) 是一种普遍的疾病,其特征是骨密度降低和骨折风险增加.
- 血管内皮生长因子 (VEGF) 在骨形成过程中起着至关重要的作用.
- 在VEGF中的遗传变异可能会影响对PMOP的敏感性.
研究的目的:
- 调查VEGF插入/删除 (I/D) 变体 (rs35569394) 和PMOP之间的关联.
- 分析VEGF基因型和等位基因在绝经后土耳其妇女队列中的分布.
主要方法:
- 一项涉及300名绝经后妇女的病例控制研究 (150名PMOP患者,150名对照).
- 使用PCR.对VEGF I/D多态的DNA提取和基因定型.
- 统计分析包括哈迪-韦恩伯格平衡,赔率比率和显著性测试 (p ≤0.05).
主要成果:
- 在PMOP患者和对照人群之间,在VEGF I/D基因型频率上没有观察到统计学上显著的差异.
- 对于VEGF I/D的等位基因频率,两组之间也没有显著的差异.
- 基因型和等位基因分布的p值分别为0.864和0.349.
结论:
- 在研究的土耳其人群中,VEGF I/D 变体 (rs35569394) 不是发展PMOP的重要风险因素.
- 这些发现表明,其他遗传或环境因素可能对PMOP发展有更大的影响.
- 建议在不同的种族群体进行进一步的验证,以概括这些结果.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Role of Vitamins in Maintaining Bone Health
3.3K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.3K
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K


